WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Equity

WhiteOak Mutual Fund

Sector - Healthcare

Get the latest NAV of WhiteOak Capital Pharma and Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹13.43

▲0.1%1D

NAV as on 24 Jun 2025

23.8%/per year

Since Inception

Absolute Gain%

▲▼

656 people have invested ₹ 62.3L in WhiteOak Capital Pharma and Healthcare Fund Direct Growth in the last three months

WhiteOak Capital Pharma and Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (24-Jun-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, but underperformed over 3Y, 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
1.5%
1.46%
0.72%
3 Months
1.08%
7.31%
1.83%
6 Months
-1.32%
3.17%
-2.84%
1 Year
26.7%
3.7%
15.33%

Peer comparison

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
WhiteOak Capital Pharma and Healthcare Fund
-
332Cr
0.68%
26.7%
-
23.8%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,689Cr
0.9%
18.7%
29.45%
18.07%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
2/8
5,508Cr
1.06%
21.97%
30.3%
22.8%
Tata India Pharma & Healthcare Fund Direct Growth
3/8
1,232Cr
0.63%
14.65%
25.95%
13.85%
See all

WhiteOak Capital Pharma and Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

WhiteOak Capital Pharma and Healthcare Fund Asset Allocation

See fund asset allocation details as on (14-Jun-25)

Fund Distribution

as on (14-Jun-25)

Equity 93.9%

Debt & Cash 6.1%

Small cap
38%
Mid cap
29.2%
Large cap
26%
Small Cap allocation has gone up from 32.4% to 38%
Small Cap allocation has gone up from 32.4% to 38%
Mid Cap allocation has gone up from 29.1% to 29.2%
Mid Cap allocation has gone up from 29.1% to 29.2%
Large Cap allocation has gone down from 31.1% to 26%
Large Cap allocation has gone down from 31.1% to 26%
Cash allocation has gone down from 6.7% to 6.1%
Cash allocation has gone down from 6.7% to 6.1%

WhiteOak Capital Pharma and Healthcare Fund Sector Allocation

See fund sector allocation details as on (14-Jun-25)

Sector Allocation

Equity 93.9%

Debt & Cash 6.1%

Health
95%
Basic Materials
3.6%
Financial Services
1.4%

Top 3 Sectors in May were Health, Government & Basic Materials

May'25

Health

95%

Government

35%

Basic Materials

4%

Apr'25

Health

96%

Government

18%

Basic Materials

4%

WhiteOak Capital Pharma and Healthcare Fund Holdings Details

as on (31-May-25)

Equity

Debt & Cash

Top Stocks bought last month
Eris Lifesciences Ltd Registered Shs's allocation increased from 1.13% to 3.33%
Eris Lifesciences Ltd Registered Shs's allocation increased from 1.13% to 3.33%
Emcure Pharmaceuticals Ltd's allocation increased from 0.66% to 2.65%
Emcure Pharmaceuticals Ltd's allocation increased from 0.66% to 2.65%
Fortis Healthcare Ltd's allocation increased from 3.54% to 5.12%
Fortis Healthcare Ltd's allocation increased from 3.54% to 5.12%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 11.31 % to 8.76 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 11.31 % to 8.76 %
Cipla Ltd's allocation decreased from 7.57 % to 5.66 %
Cipla Ltd's allocation decreased from 7.57 % to 5.66 %
Lupin Ltd's allocation decreased from 5.37 % to 4.73 %
Lupin Ltd's allocation decreased from 5.37 % to 4.73 %

WhiteOak Capital Pharma and Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.68%
Benchmark
BSE Healthcare TR INR
AUM₹332 Cr
Inception Date6 February, 2024
Min Lumpsum/SIP₹500/₹100
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
73.27%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About WhiteOak Capital Pharma and Healthcare Fund

WhiteOak Capital Pharma and Healthcare Fund Direct Growth is an equity fund. This fund was started on 6 February, 2024. The fund is managed by Piyush Baranwal. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. WhiteOak Capital Pharma and Healthcare Fund Direct Growth has ₹332 Cr worth of assets under management (AUM) as on May 2025 and is more than category average.
  2. The fund has an expense ratio 0.7.

Returns

WhiteOak Capital Pharma and Healthcare Fund Direct Growth has given a CAGR return of 23.80% since inception. Over the last 1 year the fund has given a CAGR return of 26.70%.

Holdings

WhiteOak Capital Pharma and Healthcare Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent, Government, Basic Materials, Financial Services. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Max Healthcare Institute Ltd Ordinary Shares, Cipla Ltd, Fortis Healthcare Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of WhiteOak Capital Pharma and Healthcare Fund Direct Growth

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 500.00 and for SIP is INR 100.00. WhiteOak Capital Pharma and Healthcare Fund Direct Growth has no lock in period.

Fund Manager

Piyush Baranwal

Fund Manager of WhiteOak Capital Pharma and Healthcare Fund Direct Growth, since 6 February 2024

Learn more about WhiteOak Mutual Fund
Parameters
May'25
Apr'25
Mar'25
AUM
₹ 331.7 Cr
₹ 320.4 Cr
₹ 303.6 Cr
  • AUM of the fund stands at 331.7 Cr as of May'25
  • AUM increased by 11.2 Cr between May'25 and Apr'25

Frequently Asked Questions for WhiteOak Capital Pharma and Healthcare Fund Direct Growth

How do I invest in WhiteOak Capital Pharma and Healthcare Fund?

INDmoney makes it simple to invest in the WhiteOak Capital Pharma and Healthcare Fund. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘WhiteOak Capital Pharma and Healthcare Fund’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of WhiteOak Capital Pharma and Healthcare Fund?

The NAV of the fund today is ₹13.43. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

WhiteOak Capital Pharma and Healthcare Fund fund has generated a return of 26.70% in 1 year

Who is the fund manager of WhiteOak Capital Pharma and Healthcare Fund?

The fund managers are Piyush Baranwal.

What is the exit load of the fund?

The exit load is 1% if redeemed in 0-1 Months. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 0.68%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹332 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of WhiteOak Capital Pharma and Healthcare Fund?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(8.76%), Divi's Laboratories Ltd(7.76%), Max Healthcare Institute Ltd Ordinary Shares(7.52%)